Preclinical investigation of intranasal adjuvanted COVID-19 vaccine - News-Medical.Net

3/30/2022 12:00:00 AM3 years 11 months ago

A new study reported systemic and mucosal immunity against SARS-CoV-2 via intranasal delivery of a vaccine containing recombinant SARS-CoV-2 antigens, nucleocapsid, and spike subunit.

A recent preclinical study published in Vaccines reported systemic and mucosal immunity against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) via intranasal delivery of a vaccine conta… [+5707 chars]

full article...